KENNEDY CAPITAL MANAGEMENT LLC

Position in CORT — Corcept Therapeutics Inc

CIK 884589 ST LOUIS, MO

Position in CORT

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$12,279,030

+$4,980,322 QoQ

Shares Held

304,615

+45.2% QoQ

Ownership

0.284%

of shares outstanding

% of Portfolio

0.26%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

8 quarters on record

Voting authority Sole 95.96507066296802.ToString("F0")% Shared 0.ToString("F0")% None 4.034929337031992.ToString("F0")%

Healthcare · as of Mar 31, 2026

KENNEDY CAPITAL MANAGEMENT LLC holds $354,986,312 across 62 Biotechnology names. CORT ranks #6 (3.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	484,580	$31,318,405
2	CPRX	Catalyst Pharmaceuticals, Inc.	1,199,598	$29,702,046
3	PTGX	Protagonist Therapeutics, Inc	137,099	$14,450,234
4	COGT	Cogent Biosciences, Inc.	360,490	$13,875,260
5	NAMS	NewAmsterdam Pharma Co N.V.	408,492	$13,075,828
6	CORT	Corcept Therapeutics Inc This page	304,615	$12,279,030
7	CLDX	Celldex Therapeutics, Inc.	352,302	$11,175,019
8	APGE	Apogee Therapeutics, Inc.	122,669	$10,325,049

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$12,279,030	304,615	+45.2%	Shares	Sole	2026-05-13
2025-12-31	$7,298,708	209,733	+61.4%	Shares	Sole	2026-02-13
2025-09-30	$10,798,149	129,926	+12.0%	Shares	Sole	2025-11-13
2025-06-30	$8,515,354	116,013	+35.0%	Shares	Sole	2025-08-13
2025-03-31	$9,814,125	85,923	+69.6%	Shares	Sole	2025-05-13
2024-12-31	$2,552,303	50,651	-0.5%	Shares	Sole	2025-02-13
2024-09-30	$2,355,652	50,900	+13.3%	Shares	Sole	2024-11-14
2023-12-31	$1,459,293	44,929	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.